USPSTF Recommends Providing Interventions to Support Breastfeeding
By Elana Gotkine HealthDay Reporter
TUESDAY, Oct. 22, 2024 -- The U.S. Preventive Services Task Force (USPSTF) recommends providing or referring to interventions that support breastfeeding. This recommendation forms the basis of a draft recommendation statement published online Oct. 22.
Researchers from the Agency for Healthcare Research and Quality in Rockville, Maryland, conducted a systematic review to aid the USPSTF in updating its 2016 recommendation on interventions to support breastfeeding. A total of 290 full-text articles were reviewed for inclusion; 90 randomized clinical trials assessing interventions to support breastfeeding that were initiated in, feasible for, or referable from a primary care setting were included. The researchers found mixed evidence on the effectiveness of breastfeeding support interventions on infant health outcomes, including gastrointestinal outcomes, otitis media, and the number of health care visits for respiratory tract illnesses. More favorable effects were seen in infants born in intervention versus control groups, but few differences were statistically significant. Most of the studies on maternal health outcomes reported better symptom scores among intervention versus control mothers, but differences were not statistically significant. Breastfeeding support interventions were associated with higher rates of any and exclusive breastfeeding at all time points (less than three months, three to less than six months, and six months).
Based on these findings, the USPSTF recommends providing or referring to interventions that support breastfeeding for pregnant and postpartum persons (B recommendation).
The draft evidence review and draft recommendation statement have been posted for public comment. Comments can be submitted from Oct. 22 to Nov. 18, 2024.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted October 2024
Read this next
USPSTF Guidelines of Little Value for Estimating Preeclampsia Risk in Those at Moderate Risk
WEDNESDAY, July 23, 2025 -- Moderate U.S. Preventive Services Task Force (USPSTF) preeclampsia risk factors have little value for estimating the risk for preeclampsia, according...
Specific Antiseizure Medications Associated With Major Malformations in Infants
FRIDAY, July 18, 2025 -- Maternal use of valproate, phenobarbital, and topiramate early in pregnancy is associated with an increased risk for major malformations in infants...
ENDO: Guidelines Developed for Pregnancy Care in Preexisting Diabetes
FRIDAY, July 18, 2025 -- In a joint clinical practice guideline issued by the Endocrine Society and European Society of Endocrinology, recommendations are presented for pregnancy...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.